-
). Meet Award Holders Lara Sarlak Doctor of Philosophy in Anthropology (PhD) Infrastructures of the Displaced: a case study of Istanbul Kalysha Closson Doctor of Philosophy in Population and Public Health
-
: https://www.fulbright.ca/programs/canadian-students/eligibility.html Meet Award Holders Grace Nosek Doctor of Philosophy in Law (PhD) Restorying the Climate Crisis View All Stories Further Information
-
body for applied biology professionals working with natural resources in British Columbia. The purpose of the scholarship is to provide financial assistance to a Master or Doctor of Philosophy degree
-
Megan Thomas Doctor of Philosophy in Pharmaceutical Sciences (PhD) Addressing equity considerations in research and care of patients with inflammatory arthritis View All Stories Further Information
-
View All Awards Deadline Likely in March 2025 Annual Value $20,000 Citizenship Canadian Permanent Resident International Degree Level Masters Doctoral The fellowship will provide a one-time annual stipend of $22,000 plus a research-related allowance of $1,500, as well as access to office space...
-
women for non-traditional employment, and positions in women’s centres. Meet Award Holders Kirsten McIlveen Doctor of Philosophy in Geography (PhD) Prison Paradox and Post-Secondary Education: Challenges
-
apply directly to Mitacs . Meet Award Holders Aarya Chithran Doctor of Philosophy in Neuroscience (PhD) Role of axon guidance genes in the maintenance of adult nervous system Varshaa Kumaran Master of
-
, environmental health or environmental sustainability in BC. Meet Award Holders Justin Turner Doctor of Philosophy in Rehabilitation Sciences (PhD) Wildfires, air pollution, and COVID-19: Individual and community
-
. Selected candidates will be notified by the Foundation in May. Meet Award Holders Grace Nosek Doctor of Philosophy in Law (PhD) Restorying the Climate Crisis Felix Giroux Doctor of Philosophy in Anthropology
-
of Philosophy in Population and Public Health (PhD) Identification and evaluation of implementation strategies to advance the adoption of pharmacogenomic testing to help guide antidepressant treatment for major